Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01594346Phase 3Completed
A Phase 3 trial of alpha-tocopherol in Alzheimer's disease (AD), sponsored by New York State Institute for Basic Research in Developmental Disabilities. Started Sep 2000; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01594346.